The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Outbreaks of SARS-CoV-2 may become a regular occurrence depending on the risk of reinfection, vaccine availability and efficacy, and interactions with other viruses, Mailman researchers say.
Moms with COVID-19 who take basic precautions rarely pass the virus to their newborns, even if breastfeeding and rooming together, finds a new study at Columbia University and NewYork-Presbyterian.
Video lectures and virtual labs from the Mailman School of Public Health's two-day "COVID-19 From Virus to Vaccine" course in late August are now online and available to all.
Months after recovering from a mild case of COVID-19, even healthy young adults are experiencing memory problems, fatigue, mood changes, and other neurological and psychiatric issues.
After the pandemic forced many scientists to put studies on pause, VP&S and other CUIMC researchers are back on campus with a renewed sense of purpose.
Columbia psychiatrists are developing a financial wellness program to help New Yorkers buffer the mental health impact of unemployment, financial loss, and eviction.